What's New

'Total Cases - 160,053(+735)

[Updated on May 1 [18:04]

Active

    48,573

             +735

Recovered

     108,789

+224

Deaths

       2,744

               +20

Tests Done

1,675,310

           +5,758

CountyCases
BARINGO54
BOMET148
BUNGOMA70
BUSIA1,246
ELGEYO- MARAKWET13
EMBU186
GARISSA417
HOMA BAY74
ISIOLO63
KAJIADO1,999
KAKAMEGA105
KERICHO395
KIAMBU2,815
KILIFI273
KIRINYAGA89
KISII387
KISUMU682
KITUI307
KWALE89
LAIKIPIA291
LAMU121
MACHAKOS1,355
MAKUENI168
MANDERA29
MARSABIT25
MERU175
MIGORI468
MOMBASA3,117
MURANG'A199
NAIROBI21,323
NAKURU1398
NANDI90
NAROK297
NYAMIRA34
NYANDARUA61
NYERI296
SAMBURU56
SIAYA103
TAITA TAVETA179
TANA RIVER25
THARAKA NITHI57
TRANS- NZOIA280
TURKANA284
UASIN GISHU673
VIHIGA40
WAJIR41
WEST POKOT22
Total40619

What's New

Key Insights

Oxford/AstroZeneca COVID-19 vaccine frequently asked questions

Share with a friend

What is the efficacy of the Oxford / AstraZeneca COVID-19 vaccine?

In the different clinical trials conducted, this vaccine has been shown to protect against symptomatic infections with an efficacy ranging between 60% and 90%.

According to an analysis published in The Lancet, this difference may be due to the interval between both doses: a longer interval (12 weeks) protects better (above 80%) than an interval below 6 weeks (under 60%).

Read more…